Test Research Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Test Research.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Electronic kazanç büyümesi	22.1%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Capital Investment Trends At Test Research (TWSE:3030) Look Strong

Oct 17

Test Research, Inc.'s (TWSE:3030) Popularity With Investors Under Threat As Stock Sinks 27%

Aug 05

Test Research (TWSE:3030) May Have Issues Allocating Its Capital

Jul 11

Test Research (TWSE:3030) Has Announced That Its Dividend Will Be Reduced To NT$3.30

Jun 01

Optimistic Investors Push Test Research, Inc. (TWSE:3030) Shares Up 67% But Growth Is Lacking

May 31

Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment

Jan 24

Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 05

Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?

Dec 18

Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock

Nov 30

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Test Research yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

TWSE:3030 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (TWD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	5,570	1,446	954	1,375	N/A
3/31/2024	4,779	1,186	963	1,473	N/A
12/31/2023	4,435	1,001	1,001	1,878	N/A
9/30/2023	4,540	1,043	1,081	2,020	N/A
6/30/2023	5,051	1,283	1,207	2,278	N/A
3/31/2023	5,955	1,602	1,256	2,294	N/A
12/31/2022	6,709	1,921	787	1,467	N/A
9/30/2022	6,620	1,855	342	967	N/A
6/30/2022	6,467	1,657	-13	308	N/A
3/31/2022	6,180	1,480	29	274	N/A
12/31/2021	5,607	1,185	436	591	N/A
9/30/2021	5,228	1,071	911	1,008	N/A
6/30/2021	5,202	1,093	1,115	1,192	N/A
3/31/2021	5,136	1,118	1,144	1,205	N/A
12/31/2020	4,951	1,093	1,068	1,120	N/A
9/30/2020	5,156	1,157	830	874	N/A
6/30/2020	4,840	1,061	1,072	1,122	N/A
3/31/2020	4,573	970	1,031	1,083	N/A
12/31/2019	4,387	939	1,304	1,358	N/A
9/30/2019	4,261	939	1,545	1,600	N/A
6/30/2019	4,466	961	1,292	1,341	N/A
3/31/2019	4,831	1,088	948	998	N/A
12/31/2018	4,919	1,064	576	627	N/A
9/30/2018	4,752	976	-50	-5	N/A
6/30/2018	4,616	987	-137	-91	N/A
3/31/2018	3,915	734	N/A	109	N/A
12/31/2017	3,601	595	N/A	248	N/A
9/30/2017	3,397	552	N/A	588	N/A
6/30/2017	3,017	370	N/A	345	N/A
3/31/2017	3,131	400	N/A	551	N/A
12/31/2016	3,100	429	N/A	553	N/A
9/30/2016	3,155	389	N/A	658	N/A
6/30/2016	4,012	752	N/A	805	N/A
3/31/2016	4,322	821	N/A	681	N/A
12/31/2015	4,754	999	N/A	676	N/A
9/30/2015	4,961	1,152	N/A	974	N/A
6/30/2015	6,474	1,497	N/A	1,641	N/A
3/31/2015	6,374	1,452	N/A	1,519	N/A
12/31/2014	5,870	1,260	N/A	1,155	N/A
9/30/2014	5,851	1,207	N/A	1,029	N/A
6/30/2014	4,375	830	N/A	759	N/A
3/31/2014	4,076	796	N/A	768	N/A
12/31/2013	4,084	806	N/A	1,115	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if 3030's forecast earnings growth is above the savings rate (1%).

Kazançlar ve Piyasa: Insufficient data to determine if 3030's earnings are forecast to grow faster than the TW market

Yüksek Büyüme Kazançları: Insufficient data to determine if 3030's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if 3030's revenue is forecast to grow faster than the TW market.

Yüksek Büyüme Geliri: Insufficient data to determine if 3030's revenue is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if 3030's Return on Equity is forecast to be high in 3 years time

Test Research Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Test Research, Inc. to Report Q3, 2024 Results on Nov 01, 2024

Capital Investment Trends At Test Research (TWSE:3030) Look Strong

Investor sentiment deteriorates as stock falls 18%

Second quarter 2024 earnings released: EPS: NT$1.97 (vs NT$0.87 in 2Q 2023)

Investor sentiment deteriorates as stock falls 16%

Test Research, Inc.'s (TWSE:3030) Popularity With Investors Under Threat As Stock Sinks 27%

Test Research, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Test Research (TWSE:3030) May Have Issues Allocating Its Capital

Test Research (TWSE:3030) Has Announced That Its Dividend Will Be Reduced To NT$3.30

Dividend reduced to NT$3.30

Optimistic Investors Push Test Research, Inc. (TWSE:3030) Shares Up 67% But Growth Is Lacking

Test Research, Inc. Announces Cash Dividends, Payable on July 5, 2024

Investor sentiment improves as stock rises 16%

First quarter 2024 earnings released: EPS: NT$1.93 (vs NT$1.15 in 1Q 2023)

Test Research, Inc. to Report Q1, 2024 Results on May 08, 2024

Test Research, Inc. to Report Q1, 2024 Results on May 08, 2024

Test Research, Inc.'s (TWSE:3030) 25% Share Price Surge Not Quite Adding Up

Full year 2023 earnings released: EPS: NT$4.24 (vs NT$8.13 in FY 2022)

Test Research, Inc., Annual General Meeting, May 29, 2024

Now 20% overvalued after recent price rise

Test Research, Inc. Appoints Dino Tsai as Chief Information Security Officer

Third quarter 2023 earnings released: EPS: NT$1.04 (vs NT$2.06 in 3Q 2022)

Second quarter 2023 earnings released: EPS: NT$0.87 (vs NT$2.22 in 2Q 2022)

Upcoming dividend of NT$4.50 per share at 7.0% yield

Full year 2022 earnings released: EPS: NT$8.13 (vs NT$5.02 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$2.06 (vs NT$1.22 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$2.22 (vs NT$1.47 in 2Q 2021)

Upcoming dividend of NT$3.30 per share

First quarter 2022 earnings released: EPS: NT$2.50 (vs NT$1.25 in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Test Research, Inc., Annual General Meeting, May 25, 2022

Third quarter 2021 earnings released: EPS NT$1.22 (vs NT$1.32 in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$1.47 (vs NT$1.58 in 2Q 2020)

Upcoming dividend of NT$3.30 per share

First quarter 2021 earnings released: EPS NT$1.25 (vs NT$1.14 in 1Q 2020)

Is Test Research, Inc. (TPE:3030) A Smart Choice For Dividend Investors?

With EPS Growth And More, Test Research (TPE:3030) Is Interesting

Full year 2020 earnings released: EPS NT$4.63 (vs NT$3.97 in FY 2019)

Test Research, Inc., Annual General Meeting, May 26, 2021

Test Research, Inc. Announces Change to the Research and Development Officer, Effective March 1, 2021

New 90-day high: NT$59.10

Should You Invest In Test Research (TPE:3030)?

Test Research, Inc. Announces Retirement of KuangPu Wen as Research and Development Officer

Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment

Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?

Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?

Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock

Third quarter 2020 earnings released: EPS NT$1.32

New 90-day high - NT$59.60

First half earnings released

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin